Imports weaken Indian pharma
New medicines are usually below patent safety, stopping Indian firms from producing reasonably priced generics/biosimilars. | Photograph Credit score: Getty…
New medicines are usually below patent safety, stopping Indian firms from producing reasonably priced generics/biosimilars. | Photograph Credit score: Getty…